Barben, Jürg and Southern, Kevin W ORCID: 0000-0001-6516-9083
(2020)
Why Do We Screen Newborn Infants for Cystic Fibrosis?
International journal of neonatal screening, 6 (3).
56-.
ISSN 2409-515X, 2409-515X
Text
Why Do We Screen Newborn Infants for Cystic Fibrosis.pdf - Published version Download (150kB) | Preview |
Official URL: https://www.mdpi.com/2409-515X/6/3/56
Abstract
The introduction and widespread implementation of newborn bloodspot screening (NBS) for cystic fibrosis (CF) has offered earlier diagnosis and better outcomes for children with CF in many countries of the world [...].
Item Type: | Article |
---|---|
Uncontrolled Keywords: | 3213 Paediatrics, 32 Biomedical and Clinical Sciences, Prevention, Orphan Drug, Genetics, Lung, Perinatal Period - Conditions Originating in Perinatal Period, Rare Diseases, Cystic Fibrosis, Health Services, Clinical Research, Pediatric, Genetic Testing, 4.2 Evaluation of markers and technologies, 4.1 Discovery and preclinical testing of markers and technologies, Congenital |
Depositing User: | Symplectic Admin |
Date Deposited: | 13 Jan 2021 11:09 |
Last Modified: | 22 Nov 2024 01:39 |
DOI: | 10.3390/ijns6030056 |
Related URLs: | |
URI: | https://livrepository.liverpool.ac.uk/id/eprint/3111902 |